MedTrace Logo

Cosopt Versus Xalacom

NCT00273481 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2008-11-19

No results posted yet for this study

Summary

To compare the intraocular pressure efficacy and safety of the DTFC given twice daily versus the LTFC given once every morning following a run-in period with timolol maleate given twice daily.

Conditions

Interventions

DRUG

dorzolamide 2%/timolol maleate 0.5% fixed combination

DRUG

latanoprost 0.005%/timolol maleate 0.5% fixed combination

DRUG

timolol maleate 0.5%

DRUG

placebo

Sponsors & Collaborators

  • Pharmaceutical Research Network

    lead OTHER

Principal Investigators

  • William C. Stewart, MD · Pharmaceutical Research Network, LLC

  • Cindy M. Hutnik, BSc, PhD, MD · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

  • Barbara Cvenkel, MD · University Eye Clinic Ljubljana

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2007-04-30

Countries

  • Canada
  • Slovenia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00273481 on ClinicalTrials.gov